KLOW Stack — GHK-Cu + BPC-157 + TB-500 + KPV (Separate Vials)
Comprehensive regeneration & immune modulation stack protocol
Quick Reference
Overview
The KLOW Stack is a four-peptide research formulation targeting the complete tissue healing and renewal cascade across four distinct biological pathways. GHK-Cu (50 mg) drives collagen synthesis, antioxidant gene activation, and structural remodelling through copper peptide signalling. BPC-157 (10 mg) promotes local angiogenesis, tendon healing, and nitric oxide pathway activation. TB-500 (10 mg) mobilises systemic stem cells and enhances cellular migration via actin modulation. KPV (10 mg), a tripeptide fragment of α-MSH, completes the formulation as a potent NF-κB inhibitor targeting the inflammatory phase — particularly relevant for gut, skin, and immune-related research models. Each compound is reconstituted separately and administered on its own schedule, enabling precise dose control across all four pathways simultaneously.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Daily (GHK-Cu) | 1–2 mg | 6–12 units | 0.06–0.12 mL |
| Daily (BPC-157) | 300–600 mcg | 9–18 units | 0.09–0.18 mL |
| Twice weekly (TB-500) | 2 mg | 60 units | 0.60 mL |
| Daily (KPV) | 0.5–2 mg per dose | 13–50 units | 0.13–0.50 mL |
Reconstitution Instructions
Allow all four vials to reach room temperature before handling.
Reconstitute GHK-Cu: draw 3.0 mL bacteriostatic water; inject slowly down the vial wall and swirl until dissolved. A faint blue tint is expected and normal.
Reconstitute BPC-157: draw 3.0 mL bacteriostatic water with a fresh syringe; inject and swirl gently.
Reconstitute TB-500: draw 3.0 mL bacteriostatic water with a fresh syringe; inject and swirl gently.
Reconstitute KPV: draw 2.5 mL bacteriostatic water with a fresh syringe; inject and swirl gently.
Label each vial with the compound name and reconstitution date; refrigerate all at 2–8 °C, protected from light. Use within 28 days.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓GHK-Cu Vials (50 mg): 1 vial
- ✓BPC-157 Vials (10 mg): 1 vial
- ✓TB-500 Vials (10 mg): 1–2 vials
- ✓KPV Vials (10 mg): 1–2 vials
- ✓Insulin Syringes (U-100): 120 syringes
- ✓Bacteriostatic Water (10 mL): 2 bottles
- ✓Alcohol Swabs: 240 swabs
Dosing Protocol
GHK-Cu Schedule
Inject 1–2 mg subcutaneously once daily. Rotate sites between abdomen, thighs, and upper arms.
BPC-157 Schedule
Inject 300–600 mcg subcutaneously once daily. For localized targets, inject near the area of interest for enhanced local effect.
TB-500 Schedule
Inject 2 mg subcutaneously twice weekly (e.g., Monday and Thursday). Injection site is not critical — TB-500 distributes systemically regardless of where it is administered.
KPV Schedule
Inject 0.5–2 mg subcutaneously once or twice daily. For GI-focused research, oral or rectal administration routes are also explored in the literature — consult source protocols.
Cycle Structure
Run all four compounds concurrently for 4–8 weeks, followed by a 2–4 week off period before repeating.
Storage & Handling
- ✓Lyophilized: Store all vials at −20 °C (−4 °F) in dry, dark conditions.
- ✓Reconstituted: Refrigerate each vial at 2–8 °C; keep clearly labelled and stored separately.
- ✓A faint blue tint in reconstituted GHK-Cu is normal — this is the copper-peptide complex.
- ✓Do not freeze reconstituted solutions — ice crystal formation degrades peptide integrity.
- ✓Allow vials to reach room temperature before opening to reduce condensation.
- ✓Discard any vial that becomes cloudy, unexpectedly discoloured, or develops visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Keep all four compounds in separate, clearly labelled vials — do not mix compounds in the same syringe.
- ✓Use a fresh sterile syringe for each injection and each vial puncture.
- ✓KPV is stable at physiological pH; avoid prolonged air exposure after reconstitution.
- ✓TB-500 injection site does not significantly affect its systemic distribution.
- ✓Document daily doses, injection sites, and timing for each compound separately.